MiCareo
CA - BurlingameBiotechnology
Focus: MiCareo is a public-stage biotechnology company specializing in rare cell analysis, with a focus on detecting and analyzing circulating tumor cells (CTCs) in rare disease and oncology applications.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About MiCareo
AI assessmentNot HiringNo open roles listed right now. Follow MiCareo to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
4 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Detection of Circulating Tumor Cells in Peripheral Blood From Healthy Volunteers and Patients With C
Circulating Tumor Cells (CTCs)Clinical Trials (1)
NCT02904161Detection of Circulating Tumor Cells in Peripheral Blood From Healthy Volunteers and Patients With Cancer
N/AHelp build intelligence for MiCareo
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.